Merck KGaA (OTCMKTS:MKKGY) Hits New 12-Month Low – Should You Sell?

Merck KGaA (OTCMKTS:MKKGY) reached a new 52-week low during trading on Thursday . The stock traded as low as $28.96 and last traded at $29.08, with a volume of 139382 shares traded. The stock had previously closed at $29.31.

Analyst Upgrades and Downgrades

Separately, The Goldman Sachs Group started coverage on Merck KGaA in a research note on Thursday, September 19th. They set a “buy” rating for the company.

Merck KGaA Trading Down 0.8 %

The stock has a fifty day simple moving average of $33.95 and a 200 day simple moving average of $35.05. The firm has a market capitalization of $18.79 billion, a P/E ratio of 18.09, a PEG ratio of 2.30 and a beta of 0.96. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27.

Merck KGaA Company Profile

Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company’s Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.